# Maruti Suzuki India (NSE: MARUTI) share analysis

Canonical: https://vestmind.in/stocks/maruti-suzuki  
Source: VestCall by Vestmind, price as of 14 October 2026.

> Maruti Suzuki India (NSE: MARUTI) was trading at ₹11,321 on 14 October 2026. VestCall scores its business health 68/100 (healthy). On valuation, the price sits in the “Fairly Valued” zone (₹11,202.84 – ₹11,517.16) — inside the modelled fair-value range. This is a reading of the evidence, not a buy or sell recommendation.

## Valuation zones

| Zone | Price band | Meaning |
| --- | --- | --- |
| Deeply Discounted | ₹10,438.86 – ₹11,059.45 | Furthest below the modelled fair-value range |
| Attractive Valuation | ₹11,059.45 – ₹11,202.84 | Below the modelled fair-value range |
| Fairly Valued (current) | ₹11,202.84 – ₹11,517.16 | Inside the modelled fair-value range |
| Valuation Premium | ₹11,517.16 and above | Above the modelled fair-value range |

## The case for and against

- Supports — Shareholding Quality 88/100
- Supports — Growth 78/100
- Supports — Capital Allocation 68/100
- Supports — Management Stability 67/100
- Supports — Financial Strength 65/100
- Needs proof — Business Quality 52/100

## Key ratios

| Ratio | Maruti Suzuki India | Sector median |
| --- | --- | --- |
| P/E | 10.19x | — |
| P/B | 0.48x | — |
| P/S | 0.27x | — |
| Return on equity (ROE) | 14.0% | — |
| Return on capital employed (ROCE) | 18.2% | — |
| Operating margin | 10.2% | — |
| Net margin | 7.8% | — |
| Current ratio | 1.07x | — |

## Bull, base and bear case (model outputs, not forecasts)

| Scenario | Modelled CAGR | Weight | Assumption |
| --- | --- | --- | --- |
| Bear | +2.1% | 21% | Growth decelerates to 6.1% and the multiple de-rates toward the cohort's trough. |
| Base | +17.0% | 54% | Earnings compound near the measured 17% and the multiple drifts toward its quality-adjusted warranted level. |
| Bull | +27.3% | 25% | Growth holds at 23.8% and the market pays the full premium the measured quality supports. |

## Questions

### Is Maruti Suzuki India overvalued or undervalued?

At ₹11,321, Maruti Suzuki India sits in VestCall’s “Fairly Valued” zone (₹11,202.84 – ₹11,517.16): inside the modelled fair-value range. Its valuation scores 93/100 (fair) against Unclassified peers. Zones describe where the price sits against modelled value; they are not an instruction to buy or sell.

### Is Maruti Suzuki India fundamentally strong?

VestCall scores Maruti Suzuki India’s business health 68/100 (healthy). The strongest measured pillars are shareholding quality and growth. The ones that need proof are business quality. Each pillar is computed from reported financials, and a pillar whose inputs were not reported is excluded rather than scored as zero.

### What is Maruti Suzuki India’s P/E ratio?

Maruti Suzuki India trades at a P/E of 10.19x, on VestCall’s latest read. A multiple only means something against the business it buys: the quality-adjusted fair value on this page weighs it against Maruti Suzuki India’s returns and growth.

### What are the risks of investing in Maruti Suzuki India?

The review triggers VestCall watches for Maruti Suzuki India are: return on equity falls below the quality floor (roe below 15%); drawdown from the 52-week high exceeds tolerance (drawdown from 52-week high at or beyond 25%); revenue growth falls below the thesis floor (revenue cagr below 8%). On the fundamentals, business quality is the weakest measured pillar at 52/100. A trigger is a named condition that would change the reading, published so the case against the stock is as visible as the case for it.

### Is this a recommendation to buy or sell Maruti Suzuki India?

No. VestCall states where Maruti Suzuki India’s price sits against modelled value, what supports the case and what would break it, with every figure sourced. It does not issue buy, sell or hold calls or price targets. Vestmind is not a SEBI-registered investment adviser or research analyst, and nothing on this page is personalised investment advice.

---

Vestmind is not a SEBI-registered investment adviser or research analyst. This is research for information, not a recommendation or personalised investment advice.